Clinical Trial Update: Tolerability of SLIT With LAIS® 2-Tree Allergoid Tablets

View source ↗

Summary

The trial update reports on the tolerability of SLIT with LAIS 2-Tree Allergoid Tablets in adults with allergic rhinitis, based on the completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• LAIS 2-Tree Allergoid Tablets (LAIS 2-Tree Allergoid Sublingual Immunotherapy Tablet)

Snippet

Sponsor: University Hospital of Cologne | Conditions: Allergic Rhinitis | Status: COMPLETED